Blogs
Medical Professionals

Advancing Women’s Healthcare and Empowerment: Addressing 5 Critical Barriers

The State of Women's Health Globally

Despite decades of progress in medicine and public health, women's health access remains one of the most urgent challenges of our time. According to the World Health Organisation, nearly 800 women die every day from preventable causes related to pregnancy and childbirth, a staggering statistic that represents not just medical failure, but systemic inequity.

The gap in women's healthcare empowerment is equally alarming. A 2023 report by the World Bank reveals that women spend 25% more of their lives in debilitating health compared to men, yet women's health research receives only 4% of global funding. This disconnect between need and investment has created a crisis that spans continents, cultures, and economic strata.

For pharmaceutical companies, the responsibility is clear: improving maternal health and reproductive healthcare requires more than just manufacturing medicines. It requires breaking down the barriers that prevent women from accessing them.

At Caritas Healthcare, our name means "Love for Humankind", and that love compels us to address the unique healthcare challenges women face across the 20+ countries and five continents where we operate.

Here are 5 critical barriers to women's health access and how access, education, and affordable treatment can overcome them.

Barrier #1: The Affordability Gap

The Problem

For millions of women worldwide, the cost of healthcare is the first and most insurmountable barrier. In low-income countries, out-of-pocket health expenses push 100 million people into poverty annually; with women and girls disproportionately affected.

The Numbers:

Statistics

Source

Women spend 25% more of their lives in debilitating health conditions

World Bank, 2023

Only 4% of global health research funding targets women's health specifically

NIH, 2024

800 women die daily from preventable pregnancy-related causes

WHO, 2025

 

The Solution: Affordable, Quality-Assured Medicines

Affordable treatment isn't just about low prices – it's about ensuring that cost never determines whether a woman lives or dies. At Caritas Healthcare, our manufacturing scale enables us to deliver cost-effective generics without compromising quality.

Our Production Capacity:

  • 1000 Million tablets annually

  • 350 Million capsules

  • 100 Million injectables

  • 250 Million liquids

All manufactured in WHO GMP-certified facilities with approvals from USFDA, EU-GMP, MHRA-UK, and ANVISA Brazil, ensuring that affordability never means sacrificing safety.

Barrier #2: Geographic and Infrastructure Challenges

The Problem

In rural communities across Africa, Asia, and Latin America, the nearest pharmacy or clinic may be hours away. According to UNICEF, 1 billion people lack access to a fully functional healthcare facility within one hour of their home. For pregnant women, this distance can mean the difference between life and death.

The Solution: Local Presence and Distribution Networks

This is where pharma distribution networks become a matter of life and death. Caritas has built a regional healthcare infrastructure that reaches beyond major cities into underserved communities.

Caritas' Local Footprint:

Region

Countries with Subsidiaries

Strategic Advantage

Africa

Kenya, Uganda, Tanzania

Reaching rural communities with essential medicines

Latin America

Mexico, Ecuador, Dominican Republic, Guatemala

Serving remote Andean and Central American regions

Asia

Singapore, Philippines, India

Bridging island and mainland communities

Strategic Warehouses:

  • Tlalnepantla de Baz & Tultitlán de Mariano Escobedo, México

  • Guayaquil & Quito, Ecuador

  • Multiple locations across India

The Result: End-to-end logistics through integrated sales, marketing, warehousing, and distribution networks ensure that medicines reach women wherever they live.

Barrier #3: The Education and Awareness Deficit

The Problem

Even when medicines are available and affordable, women may not seek them because they don't know they need them. Health literacy remains a critical gap, particularly in communities where women have limited access to education. A 2024 study found that only 34% of women in low-income countries could correctly identify danger signs during pregnancy.

The Solution: Patient Education and Community Engagement

At Caritas Healthcare, health education is as important as health delivery. Through our CSR initiatives, we implement patient awareness programs that empower women with knowledge.

Our Approach to Health Education:

Initiative Impact
Maternal and reproductive care education Helping women recognise danger signs and seek timely care
Health education for adolescent girls Building health literacy before pregnancy
Community health worker training Multiplying reach through local educators
Sanitation and disease prevention awareness Preventing illness before it starts

Why Education Matters: Studies show that every additional year of maternal education reduces child mortality by 9%. Educated women are more likely to seek prenatal care, recognise health emergencies, and ensure their children receive vaccinations.

Barrier #4: Cultural and Social Barriers

The Problem

In many societies, women face cultural barriers that limit their access to healthcare. These may include:

  • Requirements for male permission to seek treatment

  • Lack of female healthcare providers

  • Stigma around reproductive health issues

  • Traditional beliefs that conflict with medical advice

The Solution: Culturally Competent Healthcare Delivery

Addressing these barriers requires more than just medicine; it requires cultural understanding. Caritas' local teams bring deep knowledge of the communities they serve, enabling healthcare delivery that respects cultural contexts while advancing medical outcomes.

Our Local Advantage:

With Local Presence

Without Local Presence

Understanding of gender dynamics

One-size-fits-all approaches

Relationships with community leaders

Distant, impersonal interactions

Culturally appropriate messaging

Messages that may be missed or offend

Trust built through shared language

Language barriers and mistrust

The Result: Healthcare that works with communities, not against them.

Barrier #5: Limited Focus on Women's Health Research

The Problem

Historically, medical research has focused on male bodies, with women systematically excluded from clinical trials. This has led to significant gaps in understanding how diseases and treatments affect women differently. Women are 50% more likely to be misdiagnosed following a heart attack because symptoms present differently than in men, and medical training has historically focused on male-presenting symptoms.

The Solution: Comprehensive Therapeutic Coverage

While Caritas doesn't conduct clinical research, we ensure that our product portfolio addresses the full spectrum of women's health needs across their lifespans.

Our Therapeutic Segments Relevant to Women's Health:

Therapeutic Area

Relevance to Women

Cardiology

Heart disease is the leading cause of death for women globally

Endocrinology

Diabetes and thyroid disorders disproportionately affect women

Haematology

Anemia affects 30% of women of reproductive age worldwide

Infectious Diseases

HIV, UTIs, and other infections require gender-sensitive treatment

Dermatology

Skin conditions often have different presentations in women

All products are manufactured in WHO GMP-certified facilities with approvals from global regulators.

The Role of Pharmaceutical Companies in Women's Empowerment

Beyond Medicine: A Holistic Responsibility

Pharmaceutical companies have a unique role to play in empowering women's healthcare. Our responsibility extends beyond manufacturing to:

  1. Ensuring affordability through scale and efficiency

  2. Building distribution networks that reach rural and underserved women

  3. Supporting health education through CSR initiatives

  4. Maintaining quality that women can trust

  5. Partnering with local communities to understand and address barriers

Caritas' Commitment

At Caritas Healthcare, our mission is clear: to improve health and save lives. For women, this means:

  • 250+ product registrations ensuring medicine availability across 20+ countries

  • WHO GMP-certified facilities guarantee quality and safety

  • Local subsidiaries in 9 countries, enabling culturally competent delivery

  • CSR initiatives focused on maternal health, education, and empowerment

  • Robust pharmacovigilance monitoring of real-world safety for all patients

Empowering Women Through Access and Education: A Call to Action

The barriers to women's health access are complex and interconnected. Affordability, geography, education, culture, and research gaps don't exist in isolation; they reinforce each other, creating cycles of poor health that span generations.

Breaking these cycles requires concerted effort from all stakeholders:

  • Governments must prioritise women's health in policy and funding

  • Healthcare providers must deliver culturally competent care

  • Pharmaceutical companies must ensure affordable, quality medicines reach every woman

  • Communities must support women in seeking care

  • Women themselves must be empowered with knowledge and resources

At Caritas Healthcare, we're committed to doing our part. With operations across 20+ countries and five continents, we're working to ensure that every woman, whether in rural Kenya, urban Mexico, or coastal Philippines, has access to the quality, affordable medicines she needs to live a healthy life.

Partner With Caritas

At Caritas, we believe collaboration is key to advancing global healthcare. Whether you're a Ministry of Health seeking reliable tender partners, an NGO supporting women's health programs, or a healthcare provider serving women in your community, we're here to partner with you.

 

Build a future where every woman has access to the healthcare she deserves.

Faqs

Historically, women have been underrepresented in clinical trials, and women’s health research currently receives only 6% of private healthcare investment. This is compounded by social and financial barriers that prioritise other household needs over women’s care.

Timely access to affordable medicines and skilled birth attendants can prevent nearly 800 daily deaths related to pregnancy. When healthcare is accessible, women can manage chronic conditions like anemia or diabetes before they become life-threatening.

Beyond manufacturing, pharma companies must build resilient supply chains to prevent stockouts of essential medicines and lead CSR initiatives that bridge the gap between "having a drug" and "a patient knowing how to use it."

Health literacy is life-saving. Educated women are significantly more likely to recognise danger signs during pregnancy, seek prenatal care, and advocate for their own health within their families and communities.

Essential treatments include maternal care, injectables, iron supplements for haematology, and hormone therapies for endocrine disorders. Caritas ensures these are produced in WHO-GMP-certified facilities to guarantee global safety standards.